Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells

Eur J Cell Biol. 2018 Nov;97(8):557-567. doi: 10.1016/j.ejcb.2018.10.001. Epub 2018 Oct 22.

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a familial progressive degenerative disorder and is caused by mutations in NOTCH3 gene. Previous study reported that mutant NOTCH3 is more prone to form aggregates than wild-type NOTCH3 and the mutant aggregates are resistant to degradation. We hypothesized that aggregation or accumulation of NOTCH3 could be due to impaired lysosomal-autophagy machinery in VSMC. Here, we investigated the possible cause of accumulation/aggregation of NOTCH3 in CADASIL using cerebral VSMCs derived from control and CADASIL patients carrying NOTCH3R133C mutation. Thioflavin-S-staining confirmed the increased accumulation of aggregated NOTCH3 in VSMCR133C compared to VSMCWT. Increased levels of the lysosomal marker, Lamp2, were detected in VSMCR133C, which also showed co-localization with NOTCH3 using double-immunohistochemistry. Increased level of LC3-II/LC3-I ratio was observed in VSMCR133C suggesting an accumulation of autophagosomes. This was coupled with the decreased co-localization of NOTCH3 with LC3, and Lamp2 and, further, increase of p62/SQSTM1 levels in VSMCR133C compared to the VSMCWT. In addition, Western blot analysis indicated phosphorylation of p-ERK, p-S6RP, and p-P70 S6K. Altogether, these results suggested a dysfunction in the autophagy-lysosomal pathway in VSMCR133C. The present study provides an interesting avenue of the research investigating the molecular mechanism of CADASIL.

Keywords: Autophagy; CADASIL; LC3; Lysosomes; VSMC.

MeSH terms

  • Autophagosomes / drug effects
  • Autophagosomes / metabolism
  • Autophagy* / drug effects
  • CADASIL / pathology*
  • Chloroquine / pharmacology
  • Humans
  • Lysosomes / drug effects
  • Lysosomes / pathology*
  • MAP Kinase Signaling System / drug effects
  • Microtubule-Associated Proteins / metabolism
  • Models, Biological
  • Muscle, Smooth, Vascular / pathology*
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / pathology*
  • Phosphorylation / drug effects
  • Proteolysis / drug effects
  • Receptor, Notch3 / metabolism
  • Sequestosome-1 Protein / metabolism

Substances

  • MAP1LC3A protein, human
  • Microtubule-Associated Proteins
  • NOTCH3 protein, human
  • Receptor, Notch3
  • SQSTM1 protein, human
  • Sequestosome-1 Protein
  • Chloroquine